left

Andrew H. Beck, M.D., Ph.D.

Andrew H. Beck, M.D., Ph.D.

The goal of the Beck laboratory is to develop, apply, and integrate methods in molecular pathology, biomedical informatics, and computational image analysis for translational cancer research, leading to improved diagnostics and therapeutics for patients.

Read More →

Read More →

Stephen J. Elledge, Ph.D.

Stephen J. Elledge, Ph.D.

Dr. Elledge’s research interests center on the study of proteins that sense and respond to DNA damage and regulate the cell division cycle.

Read More →

Read More →

Irene Georgakoudi, Ph.D.

Irene Georgakoudi, Ph.D.

Dr. Irene Georgakoudi’s work focuses on the development of spectroscopic imaging approaches that rely on endogenous sources of optical contrast to characterize tissues. She is particularly interested in the use of non-invasive methods to extract quantitative biochemical, morphological and organizational cell and tissue information.

Read More →

Read More →

Gaorav Gupta, M.D., Ph.D.

Gaorav Gupta, M.D., Ph.D.

Dr. Gupta’s lab studies DNA repair processes in cancer development, metastatic progression, and responses to therapy. The primary objective of the research is to understand the diverse mechanisms that give rise to genomically complex human cancers, and to exploit this information to develop more effective therapies.

Read More →

Read More →

Piyush Gupta, Ph.D.

Piyush Gupta, Ph.D.

Dr. Gupta studies the mechanisms that generate and maintain cellular diversity in adult tissues and how the subversion of these mechanisms contributes to cancer. His laboratory investigates the genetic and cellular processes that govern adult- and cancer stem cell self-renewal and differentiation.

Read More →

Read More →

Dejan Juric, M.D.

Dejan Juric, M.D.

Director of Translational Research, Termeer Center for Targeted Therapies Clinical Director of the Breast Oncology Program, MGH Profile coming soon.

Read More →

Read More →

Top